Most deletions in prostate cancer are linked to either ERG negative cancers (i.e., deletions of 5q, 6q, 13q, 18q) or ERG positive cancers (i.e., deletions of 3p, 8p, 10q (PTEN), 12q, 16q, 17q). This evidence concerns the gene PTEN and prostate cancer.